Through our Investigator-Initiated Research (IIR) Program, we support research projects that advance medical and scientific understanding of diazoxide choline and its appropriate use in Prader-Willi syndrome (PWS), as well as its potential applications in other rare disease populations. Our goal is to enhance patient care through the generation of high-quality clinical and scientific evidence.
Depending on the nature and scope of the proposed study, Soleno may provide support for approved IIRs in the form of study medication and/or financial funding.
Request for Proposals
Click on the link below to download the Investigator-Initiated Research Request Form for more information and detailed instructions on submission.
Then, submit the completed request form and supporting documentation by email to iir@soleno.life.
